Allianceberstein Holding L.P. Press Releases

AB 
$25.15
*  
0.65
2.52%
Get AB Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading AB now
Exchange: NYSE
Industry: Finance
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AllianceBernstein Launches New Branding Initiative
1/20/2015 7:50:00 AM - PR Newswire
▼-1.72 % Price Change since this news event. The Volume Ratio is 9.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AllianceBernstein Announces December 31, 2014 Assets Under Management
1/14/2015 8:54:00 AM - PR Newswire
▼-4.08 % Price Change since this news event. The Volume Ratio is 4.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science: The Data and Safety Monitoring Board Recommends the Continuation of Phase 3 Study of Masitinib in Amyotrophic Lateral Sclerosis
1/13/2015 11:48:00 AM - GlobeNewswire


AB Science: The Data and Safety Monitoring Board Recommends the Continuation of Phase 3 Study of Masitinib in Amyotrophic Lateral Sclerosis
1/13/2015 11:48:00 AM - GlobeNewswire


AllianceBernstein Launches Multi-Manager Target-Date Series Co-managed with Morningstar Associates
1/7/2015 10:36:00 AM - PR Newswire
▲0.96 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science: report of positive clinical study data in metastatic colorectal cancer
12/18/2014 12:10:00 PM - GlobeNewswire


AllianceBernstein Announces November 30, 2014 Assets Under Management
12/10/2014 4:08:00 PM - PR Newswire
▲2.24 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science advances Ultra-Selective SYK Kinase Inhibitor into Full Preclinical Development
11/28/2014 11:58:00 AM - GlobeNewswire


AB Science: Web conference on masitinib in asthma - Safety and Efficacy Update
11/25/2014 11:55:00 AM - GlobeNewswire


AllianceBernstein Announces October 31, 2014 Assets Under Management
11/14/2014 8:20:00 AM - PR Newswire
▼-6.85 % Price Change since this news event. The Volume Ratio is 4.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science: The Data and Safety Monitoring Board recommends the continuation of the phase 2 study with masitinib in advanced hepatocellular carcinoma
11/12/2014 11:50:00 AM - GlobeNewswire


AB Science: Masitinib in Mastocytosis - Summary of Web Conference
11/10/2014 2:32:00 AM - GlobeNewswire


Peter S. Kraus, Chairman and Chief Executive Officer, to Participate in the Bank of America Merrill Lynch 2014 Banking & Financial Services Conference on November 12
11/5/2014 12:16:00 PM - PR Newswire
▼-4.01 % Price Change since this news event. The Volume Ratio is 0.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day